返回 Agenda
Session Chair(s)
Norie Miki-Yasuda, PHD
Head of Clinical Operations Europe, Canada, Australia & New Zealand
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Speaker(s)
Simultaneous Development of New Treatments in Oncology; What special challenges and opportunities exist for Japan and Asia?
Stephen Uden
Novartis Pharma K.K., Japan
Department Head, Oncology Development
New Development Opportunity at North East Asia Hub
Morihiro Watanabe, MD, PHD
Merck Serono Co., Ltd., Japan
Head, Clinical Development Center, R&D Japan, North East Asia Hub
TransCelerate – How Collaboration is it going to change the Research & Development landscape in Japan?
Toshiaki Sato, MD, PHD
Sanofi K.K., Japan
Head of Japan Clinical Sciences and Operations, R&D